We expanded our genome-wide association study on atrial fibrillation (AF) in Iceland, which previously identified risk variants on 4q25, and tested the most significant associations in samples from Iceland, Norway and the United States. A variant in the ZFHX3 gene on chromosome 16q22, rs7193343-T, associated significantly with AF (odds ratio OR ¼ 1.21, P ¼ 1. 4 Â 10 -10 ). This variant also associated with ischemic stroke (OR ¼ 1.11, P ¼ 0.00054) and cardioembolic stroke (OR ¼ 1.22, P ¼ 0.00021) in a combined analysis of five stroke samples.
AF is a common condition with a lifetime risk of one in four for men and women 40 years of age and older 1 . The disease carries considerable mortality as well as morbidity and is a major risk factor for cardioembolic stroke (CES), one form of ischemic stroke. AF increases the risk of stroke four-to fivefold across all age groups and accounts for 10-15% of all ischemic stroke 2 .
Through our initial genome-wide association study in Iceland, we identified sequence variants close to the PITX2 gene on chromosome 4q25 that confer risk of AF and atrial flutter (AFL) 3 . The association of these variants with AF has since been independently replicated 4 . To search for more variants associated with AF, we increased the sample size of this association study to 2,385 AF or AFL cases and 33,752 controls (see Supplementary Methods for description of study groups). Genotyping was performed using the Illumina HumanHap300 and HumanHapCNV370 bead chips. After quality filtering, 303,136 SNPs were tested individually for their association with AF or AFL ( Supplementary Fig. 1 ).
Of the top ten SNPs from our genome-wide analysis, the seven most significant variants corresponded to the previously reported signal on chromosome 4q25 (ref. Table 2 ). The T allele of the third SNP, rs7193343, located on chromosome 16q22 (Table 1) , showed genome-wide significant association with AF or AFL in the combined Icelandic sample set (OR ¼ 1.21, P ¼ 9.2 Â 10 À9 ). We subsequently replicated this association in the non-Icelandic samples (OR ¼ 1.22, P ¼ 0.0046). No significant heterogeneity was observed between the populations tested ( Table 1 ). The combined effect of rs7193343-T in the discovery and three follow-up sets was OR ¼ 1.21 (95% confidence interval (c.i.) 1.14-1.29) with a corresponding P value of 1.4 Â 10 À10 .
We assessed the association of rs7193343-T with AF in a Han Chinese population from Hong Kong, consisting of 286 AF cases and 2,763 controls. The association was not significant in this cohort (OR ¼ 1.05, P ¼ 0.63). Notably, the T allele of rs7193343 is much more frequent in the Han Chinese population (the allelic frequency in controls was 0.68) than the samples of European descent (the allelic frequency in controls was between 0.14 and 0.20).
In our previous genome-wide study on AF and AFL, a stronger association of the 4q25 SNPs was observed with the relatively small subset of individuals with a definite history of AFL than other cases 3 . We therefore tested rs7193343 in a subset of 160 Icelandic patients with a definite history of AFL. The association with AFL was similar to that with AF although it did not reach nominal significance on its own (OR ¼ 1.25, 95% c.i., 0.96-1.62, P ¼ 0.093).
We found no correlation between rs7193343 and obesity (for subjects with known body mass index, N ¼ 24,713, effect ¼ À1.7% of s.d., 95% c.i. À4.4% to 1.0% of s.d., P ¼ 0.22), hypertension (N hypertension cases ¼ 6,383, N controls ¼ 31,719, OR ¼ 1.00, 95% c.i. 0.95-1.06, P ¼ 0.95) or coronary artery disease (N coronary artery disease cases ¼ 2,626, N controls ¼ 33,763, OR ¼ 1.02, 95% c.i. 0.95-1.10, P ¼ 0.57) in the Icelandic sample set. This suggests that the association between rs7193343 and AF is not mediated through these known risk factors for AF.
We previously reported the results of a genome-wide association study of stroke in which the AF variants on chromosome 4q25 were found to significantly associate with ischemic stroke and with the strongest risk for the CES subtype of ischemic stroke, as was expected 5 . To assess the correlation between rs7193343 and stroke, we tested this variant in five ischemic stroke case-control sample sets consisting of people of European descent. The SNP was directly genotyped in stroke samples from West Germany, South Germany, Sweden and the UK and tested in our previously genotyped Icelandic stroke group. Combined analysis of the five datasets showed significant association between rs7193343 and ischemic stroke (OR ¼ 1.11, 95% c.i. 1.04-1.17, P ¼ 0.00054) ( Table 2 ). Association analysis of ischemic stroke subtypes showed significant association between rs7193343 and CES with an OR comparable to that of the association between rs7193343 and AF (OR ¼ 1.22, 95% c.i. 1.10-1.35, P ¼ 0.00021) ( Table 2) . No significant heterogeneity was observed between either the ischemic or cardioembolic stroke populations ( Table 2) .
The sequence variant rs7193343 is an intronic SNP located in the zinc finger homeobox 3 (ZFHX3) gene on chromosome 16q22 (Supplementary Fig. 2) , also called AT motif-binding factor 1 (ATBF1). The same variant was recently associated with Kawasaki disease, an inflammatory vasculitis predominantly seen in young children 6 . The gene encodes a transcription factor named Atbf1 that was first described as an enhancer of human a-fetoprotein (AFP) gene expression in the liver 7 . At the time of its discovery, it was the largest DNAbinding protein reported and the first protein shown to contain multiple homeodomains and multiple zinc finger motifs 7 . The gene has since been associated with regulation of growth and differentiation of several tissues, including differentiation in neuronal and skeletal muscle 8 . ZFHX3 is expressed in various tissues-for example, heart, liver, lung, kidney, pituitary gland and brain. Atbf1 is required for early transcriptional activation of the gene POU class 1 homeobox 1 (POU1F1), a member of the POU-homeodomain transcription factor family that regulates pituitary cell differentiation and hormone expression in mammals 9 . POU1F1 interacts with the paired-like homeodomain transcription factor 2 (PITX2) to facilitate DNA binding and transcriptional activity 10 , which is of interest because the previously identified AF variants on chromosome 4q25 are located Results are shown for the Icelandic discovery data set, an Icelandic follow-up data set, the two Icelandic data sets combined, and follow-up data sets from Norway and the United States; and for all the data sets combined using a Mantel-Haenzel model. The amount of heterogeneity between populations, quantified by the I 2 parameter 11 , is shown, along with the associated P values (P het ). Shown are the number of cases and controls for each study group, the frequencies in cases and in controls (in parentheses), the OR with 95% c.i., and P values assuming the multiplicative model. For the Icelandic study groups, the P and c.i. values were adjusted for relatedness as described in the Supplementary Methods. Results are shown for datasets for Iceland, Sweden, South Germany, West Germany and the UK, and for all the data sets combined using a Mantel-Haenzel model. The observed heterogeneity, quantified by the I 2 parameter 11 , was 20% (P het ¼ 0.29) for ischemic stroke and 0% (P het ¼ 0.82) for cardioembolic stroke. Shown are the number of controls and number of cases with each phenotype, the frequency (freq) in controls and in cases, the OR with 95% c.i., and P values assuming the multiplicative model. For the Icelandic study group, the P and c.i. values were adjusted for relatedness as described in Supplementary Methods.
close to PITX2, a gene critical for heart development. We did not observe association between rs7193343 and expression of ZFHX3 in blood or adipose tissue (Supplementary Table 3) .
Note: Supplementary information is available on the Nature Genetics website. 
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